Anticentromere-protein-B--DNA complex activities in anticentromere antibody-positive patients
- PMID: 1288420
- DOI: 10.1007/BF00372069
Anticentromere-protein-B--DNA complex activities in anticentromere antibody-positive patients
Abstract
Centromere protein B (CENP-B), which is an alphoid DNA binding protein, is the target antigen in autoimmune disease patients (often those with scleroderma). In this study, we analysed activities of anti-CENP-B-DNA complex in anticentromere antibody (ACA)-positive patients using DNA immunoprecipitation with purified CENP-B. The activities correlated with ACA titres and were closely associated with Raynaud's phenomenon. Patients with CREST symptoms (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia) showed higher activities than those with no symptoms. Our results suggest that autoimmune responses to native CENP-B may have an important role in the pathogenesis of scleroderma.
Similar articles
-
Anticentromere autoantibodies. Evaluation of an ELISA using recombinant fusion protein CENP-B as antigen.Arthritis Rheum. 1994 Feb;37(2):248-52. doi: 10.1002/art.1780370214. Arthritis Rheum. 1994. PMID: 8129780
-
Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.Clin Immunol. 1999 Feb;90(2):182-9. doi: 10.1006/clim.1998.4643. Clin Immunol. 1999. PMID: 10080829
-
Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.Clin Exp Immunol. 1988 Jun;72(3):465-9. Clin Exp Immunol. 1988. PMID: 3048807 Free PMC article.
-
Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F.Autoimmun Rev. 2011 Feb;10(4):194-200. doi: 10.1016/j.autrev.2010.09.025. Epub 2010 Oct 8. Autoimmun Rev. 2011. PMID: 20933614 Review.
-
Autoantibodies in scleroderma.Clin Exp Rheumatol. 1989 Sep-Oct;7 Suppl 3:S57-62. Clin Exp Rheumatol. 1989. PMID: 2691161 Review.
Cited by
-
cDNA cloning of a novel autoantigen targeted by a minor subset of anti-centromere antibodies.Clin Exp Immunol. 1998 Feb;111(2):372-6. doi: 10.1046/j.1365-2249.1998.00517.x. Clin Exp Immunol. 1998. PMID: 9486406 Free PMC article.